Welcome to our dedicated page for Oklo news (Ticker: OKLO), a resource for investors and traders seeking the latest updates and insights on Oklo stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Oklo's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Oklo's position in the market.
Oklo (NYSE: OKLO) was selected by the U.S. Department of Energy for advanced negotiations under the Surplus Plutonium Utilization Program, which aims to convert designated surplus plutonium into fuel for advanced reactors under strict U.S. security and safeguards requirements.
Oklo, partnering with European reactor developer newcleo, plans for Oklo to lead utilization of surplus plutonium while newcleo contributes fuel expertise and potential project capital, including an investment of up to $2 billion for U.S. fuel fabrication infrastructure, subject to definitive agreements and approvals. In February 2026, newcleo began pre-application engagement with the U.S. Nuclear Regulatory Commission for an advanced fuel fabrication facility and a lead-cooled fast reactor design to support future U.S. deployment.
Oklo (NYSE: OKLO) released its first quarter 2026 financial results and business update for the period ended March 31, 2026. The company will host a conference call on May 12, 2026 at 2:00 p.m. PT / 5:00 p.m. ET.
The webcast, featuring CEO Jacob DeWitte and CFO Craig Bealmear, will be available through the investor relations Events & Presentations page and archived for 12 months.
Oklo (NYSE: OKLO) announced a Strategic Partnership Project with Battelle Energy Alliance at Idaho National Laboratory to apply the Prometheus AI platform to advanced reactor and fuel-system design.
The collaboration supports the federal Genesis Mission and development of Oklo’s Pluto reactor using AI-enabled engineering workflows.
Oklo (NYSE: OKLO) announced the U.S. Nuclear Regulatory Commission approved its Principal Design Criteria (PDC) topical report for the Aurora powerhouse in Idaho on an accelerated review schedule.
The approval permits future applications to reference the PDC, reduces re-review of established material, and was completed in less than half the traditional timeline, with acceptance notice issued in 15 days.
Oklo (NYSE: OKLO) will release first-quarter 2026 financial results after market close on Tuesday, May 12, 2026, followed by a business-update conference call at 5:00 p.m. ET / 2:00 p.m. PT.
Jacob DeWitte, CEO, and Craig Bealmear, CFO, will host. The live webcast and replay, dial-in details, meeting ID, and investor presentation will be available on Oklo’s investor website.
Oklo (NYSE: OKLO) announced an agreement with NVIDIA and Los Alamos National Laboratory to advance AI-enabled nuclear fuel validation, materials R&D, and grid reliability studies at Los Alamos in support of the federal Genesis Mission. Initial work targets plutonium-bearing fuel validation for Oklo's Pluto reactor and integrated nuclear-powered AI factory concepts.
Oklo (NYSE: GL) announced board and management changes effective April 10, 2026, adding four new directors and naming a lead independent director to support faster deployment across its power, fuel, fuel recycling, and isotopes businesses.
Oklo will transition Pat Schweiger from CTO to senior technical advisor and appointed Michael Thompson as Lead Independent Director to strengthen execution and technical oversight.
Oklo (NYSE: OKLO) and Blykalla expanded a transatlantic strategic partnership to broaden collaboration on fast reactor commercialization. Blykalla plans U.S. capital and engineering contributions on the scale of $100–200 million and 30–40 engineers, subject to final planning and approvals.
The agreement targets reactor pilot project support, neutronics and thermohydraulics analyses, and exploration of fast‑neutron irradiation testing using Oklo facilities, all within applicable U.S. laws, export controls and DOE program frameworks.
Oklo (NYSE: OKLO) announced that CEO and co-founder Jacob DeWitte was appointed to the U.S. President’s Council of Advisors on Science and Technology (PCAST) on March 25, 2026. DeWitte will join leaders from science, engineering, and industry to advise on national science and technology policy.
The Council is co-chaired by David Sacks and Michael Kratsios and includes senior figures from technology and business.
Oklo (NYSE: OKLO) announced U.S. Department of Energy approval of the Nuclear Safety Design Agreement (NSDA) for Atomic Alchemy’s Groves Isotopes Test Reactor in Lockhart, Texas. The NSDA clears the facility to submit its Preliminary Documented Safety Analysis (PDSA) and move into the next DOE-reviewed execution phase.
The subsidiary previously signed an Other Transaction Agreement (OTA) and is targeting criticality by July 4, 2026. The pilot aims to develop domestic radioisotope production capacity for medical, research, space, and national security uses.